• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CERAPEDICS INC. I-FACTOR PUTTY; FILLER, BONE VOID, SYNTHETIC PEPTIDE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CERAPEDICS INC. I-FACTOR PUTTY; FILLER, BONE VOID, SYNTHETIC PEPTIDE Back to Search Results
Model Number 900-010
Device Problem Migration (4003)
Patient Problem Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 07/13/2023
Event Type  Injury  
Manufacturer Narrative
The design history record was reviewed for lot 21c1004 and indicated no abnormal processing.The lot in question met all specifications prior to its release.There have been no ncrs or capas associated with this lot.Cerapedics risk analysis document (b)(4), revision 23 (putty) was reviewed.The failure mode identified in this complaint is already identified under line item 38 (potential effect 2) - "inadequate retention in graft site, migration." therefore, no updates to the risk assessment are required.There have been 9 (nine) previous complaints related to this potential failure mode.Based on the total number of units distributed (n=265,783), the observed rate is (b)(4).The mitigated risk probability for this potential failure mode is estimated to be 1 or an estimated occurrence rate of (b)(4) therefore, the benefit-risk analysis remains unchanged.Ous putty ifu (p/n 40002-01-10) lists the following as a potential adverse effect: "extrusion or migration of the bone void filler, as is possible with any bone void filler, resulting in pain, neural impingement, physical impairment, irritation or wear of an articulating joint, or loss of function; any of which my require revision surgery." as such, no updates are required for the ifu.
 
Event Description
I-factor migrated out of cervical cage and spread over the dura mater and left c5 and c6 foramen.Revision surgery to remove i-factor.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
I-FACTOR PUTTY
Type of Device
FILLER, BONE VOID, SYNTHETIC PEPTIDE
Manufacturer (Section D)
CERAPEDICS INC.
11025 dover street
suite #1600
westminster CO 80021
Manufacturer Contact
emily aulby
11025 dover street
suite #1600
westminster, CO 80021
MDR Report Key18886929
MDR Text Key337453737
Report Number3007155473-2024-23139
Device Sequence Number1
Product Code NOX
UDI-Device Identifier00850001680158
UDI-Public(01)00850001680158(17)240630(10)21C1004
Combination Product (y/n)Y
Reporter Country CodeFR
PMA/PMN Number
P140019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 03/11/2024
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number900-010
Device Lot Number21C1004
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 07/18/2023
Initial Date FDA Received03/12/2024
Supplement Dates Manufacturer Received07/18/2023
Supplement Dates FDA Received03/25/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured06/13/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNKNOWN CERVICAL CAGE
Patient Outcome(s) Other;
Patient Age39 YR
Patient SexMale
-
-